HSTM vs ZBH: fair value comparison
HealthStream, Inc. and Zimmer Biomet Holdings, Inc. · Updated 2026-09-12
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, HSTM currently sits closer to the top of our discount ranking. ZBH carries the stronger quality grade.
| HSTM | ZBH | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $29.67 | $93.49 |
| 12-month range | $20.34–$29.67 | $82.90–$100.56 |
| Sector rank | #34 of 113 Healthcare | #37 of 113 Healthcare |
| Quality grade | D | B |
| Momentum grade | — | B |
| Leverage | Low | Moderate |
| Margin trend | Stable | Contracting |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Uptrend | — |
| DCF cross-check | Undervalued | Undervalued |
| 52-week position | The top quarter | The upper-middle quarter |
Full single-stock breakdowns: HSTM fair value analysis · ZBH fair value analysis